Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The objective of the Phase 2 study is to compare the safety and efficacy of cis-UCA
Ophthalmic Solutions to placebo for the treatment of the signs and symptoms of dry eye.